Practical Diagnostic Strategy for Feline Toxoplasmosis: Combining Serology and Molecular Testing

Diagnosing Toxoplasma gondii infection in cats is not always straightforward. A single diagnostic method may produce false-positive or false-negative results, particularly when the infection stage, sample type, or antibody response affects test performance. For practicing veterinarians, a structured diagnostic strategy that combines clinical assessment with appropriate serological and molecular testing can provide a more reliable evaluation of infection status. 

Start With Clinical Assessment and Exposure History 

Diagnostic evaluation should begin with the cat’s clinical presentation and history of potential exposure to sources of T. gondii infection. In asymptomatic cats with a possible exposure history, serological testing can be used as the initial screening approach^1,2. 

This approach allows the veterinarian to begin with a relatively accessible method before proceeding to more technically demanding molecular testing. The result should, however, be interpreted according to the overall clinical context rather than considered in isolation. 

Use Serology for Initial Screening 

Serological methods such as ELISA and the modified agglutination test (MAT) are widely used for preliminary screening because of their ease of use, relatively rapid turnaround, and suitability for larger-scale testing¹. 

Immunochromatographic tests can provide another option when rapid preliminary results are required. Their simple format can minimize problems associated with sample transport and storage and may allow preliminary interpretation at the point of testing¹. 

However, a negative antibody-based result does not necessarily exclude infection in every situation. During early infection, antibody levels may remain below the detection threshold, creating a potential for false-negative interpretation³. 

When to Move to Molecular Confirmation 

If serological findings are inconclusive, molecular methods such as PCR can be used to support confirmation of infection [119,120]. PCR detects T. gondii-specific DNA and can be applied to samples including blood, feces, and tissue. 

The choice of sample and testing method should be considered carefully because molecular detection depends on the presence of detectable parasite DNA in the submitted material. PCR therefore complements rather than simply replaces serological testing. 

Using serological screening followed by molecular confirmation provides a two-stage diagnostic strategy. This approach can improve diagnostic specificity and sensitivity while allowing the initial screening method to identify samples that require additional evaluation. 

Standardize Sample Handling 

The reliability of molecular diagnosis depends not only on the analytical test but also on how the sample is collected and handled. Because PCR requires specialized laboratory conditions, standardized procedures should be followed for sample collection, handling, transportation, and storage^4,5. 

Maintaining sample integrity is particularly important when samples must be transported from veterinary practices to diagnostic laboratories. Consistent procedures help reduce variability and improve the reliability of the final result. 

Interpreting Results as a Combined Picture¹ 

Diagnostic interpretation should incorporate both serological and molecular findings rather than relying automatically on one test result. Standardized criteria for interpreting results can help reduce inter-laboratory variability and diagnostic errors. 

Once infection has been confirmed, management should consider the cat’s clinical presentation, infection severity, and overall health status. Symptomatic cats require timely treatment and monitoring, whereas asymptomatic cats may be managed through regular observation of changes in infection status. 

Routine surveillance is also relevant in populations with increased environmental exposure. Wild cats require particular attention because their wide-ranging behaviour can increase exposure to environmental sources of T. gondii. In endemic areas, regular antibody screening of wildcat populations has been recommended. 

Key Takeaways 

• Begin diagnostic evaluation with clinical assessment and exposure history. 

• Serological testing is appropriate as an initial screening approach in asymptomatic cats with possible exposure. 

• ICT, ELISA and MAT can support preliminary screening, depending on the diagnostic setting. 

• Consider PCR when serological findings are inconclusive or molecular confirmation is required. 

• Standardize sample collection, handling, transportation, and storage for molecular testing. 

• Interpret serological and molecular findings together rather than relying on a single result. 

• Apply standardized interpretation criteria to reduce diagnostic variability. 

• Confirmed cases should be managed according to clinical presentation, infection severity, and overall health status. 

• Epidemiological surveillance can help identify populations requiring closer monitoring, particularly wild cats in endemic areas. 

References 

1. Zhao D, Liao Y, Liu H, Wang J, Liang R, Zhou R, Ding J, Zhang S, Tang X. Comprehensive diagnostic approaches to feline toxoplasmosis: Bridging traditional methods and emerging technologies. Virulence. 2025 Dec 31;16(1):2563766. https://www.tandfonline.com/doi/pdf/10.1080/21505594.2025.2563766 

2. Rostami A, Karanis P, Fallahi S. Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection. infection. 2018 Jun;46(3):303-15. https://link.springer.com/article/10.1007/s15010-017-1111-3 

3. Kim MJ, Park SJ, Park H. Trend in serological and molecular diagnostic methods for Toxoplasma gondii infection. European journal of medical research. 2024 Oct 28;29(1):520. https://link.springer.com/content/pdf/10.1186/s40001-024-02055-4.pdf 

4. Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites & vectors. 2015 May 28;8(1):292. https://link.springer.com/content/pdf/10.1186/s13071-015-0902-6.pdf 

5. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical microbiology reviews. 2012 Apr;25(2):264-96. https://pmc.ncbi.nlm.nih.gov/articles/PMC3346298/pdf/zcm264.pdf